BMCC’s Medical Device Division: A bridge for connecting academia-research R&D endeavors.

Welcome to BMCC

The BioMed Commercialization Center (BMCC) is a joint establishment by the Taiwan Instrument Research Institute, National Applied Research Laboratories and the Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute. Through value-added innovation, prototyping services, and accelerating commercialization, it aims to bring together R&D results from academia and the research community, translate them into products meeting clinical needs, and help companies overcome commercialization barriers, thereby facilitating their penetration of international markets.

Our Service

  • Industry mentors

    Specialized guidance of veterans from related institutions and industries: medical electronics, materials, minimally invasive surgery, machinery, IVD, AI, digital health, IoT
  • Taxes and equities

    Guidance in the incorporation and commercialization process, including shareholding structures, accounting, taxation, import and export affairs
  • Incubation & acceleration

    Organization of matching events from time to time to solicit overseas and domestic capital; guidance on applying for government subsidies and gaining access to incubative institutions
  • Policy & law

    Legal counseling in the medical devices sector
  • Regulations & patents

    Statutory counseling on bringing products to market and securing patents
  • Marketing

    Guidance on international operations and connections, introduction of domestic and overseas funds and partnerships, marketing of innovative products
  • Business management

    Management training, guidance on market and product positioning, “go-to-market” training
  • Clinical verification

    Assistance and counseling for planning clinical trials; provision of links to CROs and testing institutions
  • Prototyping services

    Collaboration with domestic institutions to meet the prototyping needs of local startups in different phases and assist in migrating toward commercialization

Our achievements so far:

  • 0 teams assisted
  • 0 startups established
  • 0 billion Taiwan dollars of capitalization
  • 0 firms assisted in securing certification